Loading Aristo Bio-Tech And Lifescience…
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 364 | 318 | 245 | 218 | — |
| Operating profit | 13 | 7 | 7 | 7 | — |
| Operating margin | 3.6% | 2.2% | 3.0% | 3.3% | — |
| Net profit | 7 | 4 | 4 | 4 | — |
| Net margin | 2.0% | 1.3% | 1.6% | 1.6% | — |
| EPS (₹) | — | 5.97 | 5.72 | 6.72 | 2.11 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Total assets | 155 | 141 | 127 | 100 |
| Total liabilities | 111 | 103 | 94 | 70 |
| Shareholders’ equity | 44 | 37 | 34 | 30 |
| Total debt | 35 | 22 | 21 | 22 |
| Cash & equivalents | 3 | 1 | 1 | 2 |
| Debt / equity | 0.80 | 0.59 | 0.62 | 0.75 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Operating cash flow | 9 | 10 | 8 | -3 |
| Capital expenditure | -3 | -5 | -7 | -4 |
| Free cash flow | 6 | 5 | 1 | -7 |
| ₹ Cr | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Return on equity | 16.3% | 10.9% | 11.6% | 11.8% |
| Return on assets | 4.6% | 2.9% | 3.1% | 3.6% |
| Net margin | 2.0% | 1.3% | 1.6% | 1.6% |
Source: Yahoo Finance. Figures in ₹ crore unless stated.
No analyst data available for ARISTO. Finnhub coverage is limited for some India-listed stocks.